Urs Brändli
Chief Tech/Sci/R&D Officer bei DOTTIKON ES HOLDING AG
Vermögen: 1 Mio $ am 31.03.2024
Profil
Urs Brändli ist Head-Processes & Technologies bei der Dottikon Es Holding AG.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
DOTTIKON ES HOLDING AG
0,03% | 31.03.2023 | 4 050 ( 0,03% ) | 1 Mio $ | 31.03.2024 |
Aktive Positionen von Urs Brändli
| Unternehmen | Position | Beginn |
|---|---|---|
| DOTTIKON ES HOLDING AG | Chief Tech/Sci/R&D Officer | 01.01.2003 |
Dottikon Exclusive Synthesis AG
 Dottikon Exclusive Synthesis AG Pharmaceuticals: MajorHealth Technology Dottikon Exclusive Synthesis AG manufactures pharmaceutical ingredients. Its products and services exclusive synthesis, project management, performance chemicals, containment, quality management, recycling and waste treatment, and dottisol. The company was founded in 1913 and is headquartered in Dottikon, Switzerland. | Corporate Officer/Principal | - |
| Dottikon Es Management AG | Corporate Officer/Principal | - |
Swiss Chemical Society
 Swiss Chemical Society Miscellaneous Commercial ServicesCommercial Services Swiss Chemical Society provides accounting services. The non-profit company is based in Bern, Switzerland. | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| DOTTIKON ES HOLDING AG | Process Industries |
| Private Unternehmen | 3 |
|---|---|
Swiss Chemical Society
Swiss Chemical Society Miscellaneous Commercial ServicesCommercial Services Swiss Chemical Society provides accounting services. The non-profit company is based in Bern, Switzerland. | Commercial Services |
Dottikon Exclusive Synthesis AG
Dottikon Exclusive Synthesis AG Pharmaceuticals: MajorHealth Technology Dottikon Exclusive Synthesis AG manufactures pharmaceutical ingredients. Its products and services exclusive synthesis, project management, performance chemicals, containment, quality management, recycling and waste treatment, and dottisol. The company was founded in 1913 and is headquartered in Dottikon, Switzerland. | Health Technology |
| Dottikon Es Management AG |
